Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Literature DB >> 34552263

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Jack M Lawrence¹, Gideon Meyerowitz-Katz², James A J Heathers³, Nicholas J L Brown⁴, Kyle A Sheldrick⁵.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34552263 DOI： 10.1038/s41591-021-01535-y

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

Authors: Joshua D Brown; Amie J Goodin
Journal: Med Cannabis Cannabinoids Date: 2022-02-25

2. Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients.

Authors: Arman Shafiee; Mohammad Mobin Teymouri Athar; Omid Kohandel Gargari; Kyana Jafarabady; Sepehr Siahvoshi; Sayed-Hamidreza Mozhgani
Journal: Virol J Date: 2022-06-13 Impact factor: 5.913

3. High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

Authors: Dora Buonfrate; Fabio Chesini; Davide Martini; Maria Carla Roncaglioni; Maria Luisa Ojeda Fernandez; Maria Francesca Alvisi; Irene De Simone; Eliana Rulli; Alessandro Nobili; Giacomo Casalini; Spinello Antinori; Marco Gobbi; Caterina Campoli; Michela Deiana; Elena Pomari; Gianluigi Lunardi; Roberto Tessari; Zeno Bisoffi
Journal: Int J Antimicrob Agents Date: 2022-01-06 Impact factor: 5.283

Review 4. Signals were broadly positive for months, but never definitive: the tocilizumab story.

Authors: Alessandro Cozzi-Lepri; Colette Smith; Cristina Mussini
Journal: Clin Microbiol Infect Date: 2021-11-09 Impact factor: 8.067

Review 5. Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective.

Authors: J Carlos Menéndez
Journal: Molecules Date: 2022-01-20 Impact factor: 4.411

6. Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis.

Authors: Avi Bitterman; Caitlin Pestana Martins; Ahuva Cices; Makarand Prasad Nadendla
Journal: JAMA Netw Open Date: 2022-03-01

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

1. Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

2. Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients.

3. High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

Review 4. Signals were broadly positive for months, but never definitive: the tocilizumab story.

Review 5. Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective.

6. Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis.

7. The new normal? Redaction bias in biomedical science.

Review 8. COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

9. Why and how we should join the shift from significance testing to estimation.

10. Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model.